- •DeepSeek V4 Flash argues EXIT because The trade should be closed because price is failing at the first adverse barrier ($248.10 resistance) with deteriorating momentum across all timeframes. The stock is showing material relative weakness vs QQQ (+1.25% vs -1.04%), positive news is being sold into, and volume is at the 2nd percentile — no conviction behind the move. With only 6.3% of target progress achieved after 6 days and the 30-min chart showing a bearish micro-structure, the risk/reward has shifted against holding.
- •What changed: Price failed to break 4h resistance $248.10 despite positive catalyst. Momentum deteriorated across all timeframes. Relative weakness vs QQQ emerged. Volume collapsed to 2nd percentile. 30-min chart turned bearish with RSI 37 and MACD zero-cross.
No model defended HOLD.
The trade should be closed because price is failing at the first adverse barrier ($248.10 resistance) with deteriorating momentum across all timeframes. The stock is showing material relative weakness vs QQQ (+1.25% vs -1.04%), positive news is being sold into, and volume is at the 2nd percentile — no conviction behind the move. With only 6.3% of target progress achieved after 6 days and the 30-min chart showing a bearish micro-structure, the risk/reward has shifted against holding.
The long thesis is stalling: price is pinned under 4h SMA20 ($248.16), 1day resistance ($250.02) and 1day SMA50 ($251.16), momentum is rolling over across 4h/30m timeframes, and volume is depressed at the 2nd percentile so there is no fuel for the required breakout. AMZN is diverging idiosyncratically from a strongly higher QQQ (+1.25% vs -1.04%), and progress has decayed from a 55.6% peak to just 6.3% with the effective stop already at breakeven, leaving little upside R/R against a blocked path to $258.
The trade should be closed because the original thesis is invalidated. AMZN has failed to break and hold above the critical $250.02 resistance level, momentum indicators are weakening, and volume participation is depressed. The stock is underperforming its sector and beta proxy (QQQ), signaling idiosyncratic weakness. With near-term catalysts (earnings, FTC settlement) introducing uncertainty, the risk/reward profile has deteriorated.
Individual Model Review
The long thesis is stalling: price is pinned under 4h SMA20 ($248.16), 1day resistance ($250.02) and 1day SMA50 ($251.16), momentum is rolling over across 4h/30m timeframes, and volume is depressed at the 2nd percentile so there is no fuel for the required breakout. AMZN is diverging idiosyncratically from a strongly higher QQQ (+1.25% vs -1.04%), and progress has decayed from a 55.6% peak to just 6.3% with the effective stop already at breakeven, leaving little upside R/R against a blocked path to $258.
Round-tripped from 55.6% peak progress to breakeven with the effective stop at entry, price stalled under stacked resistance ($248-251) on depressed volume and rolling-over momentum, and idiosyncratic weakness vs a +1.25% QQQ — the path to $258 is blocked and R/R has collapsed, so close the position rather than risk a fade into the Jul 30 earnings event.
The long thesis is stalling: price is pinned under 4h SMA20 ($248.16), 1day resistance ($250.02) and 1day SMA50 ($251.16), momentum is rolling over across 4h/30m timeframes, and volume is depressed at the 2nd percentile so there is no fuel for the required breakout. AMZN is diverging idiosyncratically from a strongly higher QQQ (+1.25% vs -1.04%), and progress has decayed from a 55.6% peak to just 6.3% with the effective stop already at breakeven, leaving little upside R/R against a blocked path to $258.
▼ Click to expandPrice is still ~0.3% above entry and above 1day support $243.78 and POC $244.25, with the 1day MACD histogram positive and Truist reiterating Buy at $330. If QQQ leadership broadens back into AMZN and it clears $248-250, the $258 target remains reachable within horizon before the Jul 30 earnings catalyst.
▼ Click to expandThe trade should be closed because price is failing at the first adverse barrier ($248.10 resistance) with deteriorating momentum across all timeframes. The stock is showing material relative weakness vs QQQ (+1.25% vs -1.04%), positive news is being sold into, and volume is at the 2nd percentile — no conviction behind the move. With only 6.3% of target progress achieved after 6 days and the 30-min chart showing a bearish micro-structure, the risk/reward has shifted against holding.
Thesis invalidated: price pinned at first adverse barrier $248.10 with failing momentum, relative weakness vs QQQ (+1.25% vs -1.04%), positive news being sold into, and volume at 2nd percentile. Only 6.3% of target achieved after 6 of 15 days.
The trade should be closed because price is failing at the first adverse barrier ($248.10 resistance) with deteriorating momentum across all timeframes. The stock is showing material relative weakness vs QQQ (+1.25% vs -1.04%), positive news is being sold into, and volume is at the 2nd percentile — no conviction behind the move. With only 6.3% of target progress achieved after 6 days and the 30-min chart showing a bearish micro-structure, the risk/reward has shifted against holding.
▼ Click to expandThe position could still be held if the $248.10 resistance breaks on the positive Amazon Business catalyst and the stock resumes its path toward $258. The 1-day SMA20 at $243.07 provides a rising floor, and the original thesis of AWS growth and e-commerce strength remains intact for the July 30 earnings catalyst.
▼ Click to expandThe trade should be closed because the original thesis is invalidated. AMZN has failed to break and hold above the critical $250.02 resistance level, momentum indicators are weakening, and volume participation is depressed. The stock is underperforming its sector and beta proxy (QQQ), signaling idiosyncratic weakness. With near-term catalysts (earnings, FTC settlement) introducing uncertainty, the risk/reward profile has deteriorated.
The original thesis is invalidated due to a failed breakout at $250.02, weakening momentum, depressed volume, and underperformance vs. QQQ and sector. The risk/reward profile has deteriorated, warranting an exit.
The trade should be closed because the original thesis is invalidated. AMZN has failed to break and hold above the critical $250.02 resistance level, momentum indicators are weakening, and volume participation is depressed. The stock is underperforming its sector and beta proxy (QQQ), signaling idiosyncratic weakness. With near-term catalysts (earnings, FTC settlement) introducing uncertainty, the risk/reward profile has deteriorated.
▼ Click to expandThe original thesis for holding AMZN relied on a confirmed breakout above $250.02, sustained bullish momentum, and leadership within the tech sector. The position was expected to target $258, supported by strong volume and alignment with a bullish regime. However, these conditions are no longer met.
▼ Click to expandRun Summary
Intraday discovery triggered reanalysis on AMZN. Verdict: EXIT (3/3 EXIT). Conviction: 44.